Noida, UP -- (SBWire) -- 05/15/2015 --The recent discovery of miRNA and the recognition of its diagnostic and therapeutic potential has sparked off a lot of interest, as evident from the clinical trials being carried on in diverse fields. At the geographical front, the Americas emerge as leaders when it comes to miRNA based research, accounting for 55% of the toal ongoing research.
The report "Global miRNA Market Outlook to 2018", covers present and future outlooks for the two broad categories of miRNA; tools and services segments. The former comprises various tools that are used to study miRNA and the latter includes various services such as purification, expression profiling etc.
The market has been divided into three sections: The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players.
Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are applied to control gene translation and consequently its expression.
After an exhaustive study of the industry, RNCOS has laid out the primary market players which are engaged in providing miRNA based tools and services. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors, and constantly upgrading their portfolio to keep up with the latest developments in the field. Some of these players include Qiagen, Life Technologies, Exiqon and Mirus Bio.
Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM649.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
The Americas: Hub for miRNA Research
‘Active research environment, generous funding and high standards of research infrastructure and intellect are helping the Americas emerge as a hub for miRNA Based research’, says RNCOS.